NCT00375583View on ClinicalTrials.gov

Effect of Albendazole Dose on Clearance of Filarial Worms

PHASE2CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 9, 2006

Primary Completion Date

April 28, 2011

Study Completion Date

April 28, 2011

Conditions
Lymphatic FilariasisWuchereria Bancrofti Infection
Interventions
DRUG

DEC/Albendazole

Trial Locations (1)

Unknown

Tuberculosis Research Centre, Chennai

All Listed Sponsors
collaborator

Tuberculosis Research Centre, India

OTHER_GOV

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00375583 - Effect of Albendazole Dose on Clearance of Filarial Worms | Biotech Hunter | Biotech Hunter